Investigating documented reasons for withdrawal from clinical trials for patients with advanced prostate cancer (PCa). Clinical outcomes of abiraterone acetate (AA) or enzalutamide (E) as first-line ...

To report on the 15-year prostate cancer experience of our multidisciplinary genitourinary cancer clinic established in 1996 at the National Cancer Institute (NCI) –designated Jefferson Kimmel Cancer ...

CIRT leads to temporary urinary function decline, normalizing within three months and stable for five years. Prostate volume decreases significantly without ADT, remaining reduced for five years. T ...